The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay ...
Rising costs coupled by flat rates set by the Trump administration for Medicare Advantage could trigger withdrawals of health insurers from markets across the U.S.
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2025 Earnings Call Transcript February 5, 2026 Adaptive Biotechnologies ...
Although hospital-owned plans are only a sliver of the Medicare Advantage market, their enrollment continues growing.
Ever since Larry Wilkewitz retired more than 20 years ago from a wood products company, he's had a commercial Medicare Advantage plan from the insurer Humana.
A key House bill aims to save money on Indiana's struggling managed Medicaid program, and in turn, possibly alleviate the ...
Healthcare fraud continues to plague providers, managed care, and drug companies. $5.7 billion of the $6.8 billion recovered by DOJ was generated ...
Gene therapy drugs have the potential to cure some diseases, but some have a price tag of over a million dollars. Who gets access to them and who doesn't?
Be sure to catch The Dinner Detective True Crime Murder Mystery Dinner Show - Louisville, KY on the Louisville Patch calendar ...
Federal officials have a plan that could curb billions of dollars in overpayments to Medicare Advantage plans. But will they ...
Medicare Advantage health plans are blasting a government proposal this week that would keep their reimbursement rates flat ...
Shares in Elevance Health fell 14% on Tuesday and another 6% in premarket trading Wednesday following a proposal from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results